Cardiovascular outcomes with icosapent ethyl by burden of standard modifiable cardiovascular risk factors in REDUCE-IT
Fuente:
PubMed "nature biotechnology"
Am J Prev Cardiol. 2026 Feb 2;26:101458. doi: 10.1016/j.ajpc.2026.101458. eCollection 2026 Apr.NO ABSTRACTPMID:42006413 | PMC:PMC13084092 | DOI:10.1016/j.ajpc.2026.101458